EGCG‐enabled Deep Tumor Penetration of Phosphatase and Acidity Dual‐responsive Nanotherapeutics for Combinatory Therapy of Breast Cancer
Small · 2025
DOI: 10.1002/smll.202406245 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Mengxue Zhou und 16 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Tea Biology and Resource Utilization of Ministry of Agriculture, Tea Research Institute, Chinese Academy of Agricultural Sciences, …. Hauptthemen laut MEDLINE: Catechin, Triple Negative Breast Neoplasms, Breast Neoplasms, Nanomedicine. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: Central Public-interest Scientific Institution Basal Research Fund, Chinese Academy of Agricultural Sciences, Zhejiang Provincial Outstanding Youth Science Foundation.
Abstract (Originalsprache)
The presence of dense collagen fibers is a typical characteristic of triple‐negative breast cancer (TNBC). Although these fibers hinder drug penetration and reduce treatment efficacy, the depletion of the collagen matrix is associated with tumor metastasis. To address this issue, epigallocatechin‐3‐gallate (EGCG) is first exploited for disrupting the dense collagenous stroma and alleviate fibrosis by specifically blocking the TGF‐β/Smad pathway in fibroblasts and tumor cells when intraperitoneally administrated in TNBC tumor‐bearing mice. A methotrexate (MTX)‐loaded dual phosphate‐ and pH‐responsive nanodrug (pHA@MOF‐Au/MTX) is next engineered by integrating Fe‐based metal–organic frameworks and gold nanoparticles for improved chemo/chemodynamic therapy of TNBC. Surface modification with pH (low)‐insertion peptide substantially enhanced the binding of the nanodrug to 4T1 cells owing to tumor stroma remodeling by EGCG. High‐concentration EGCG inhibited glutathione peroxidase by regulating mitochondrial glutamine metabolism, thus facilitating tumor cell ferroptosis. Furthermore, sequential EGCG and pHA@MOF‐Au/MTX treatment showed remarkable anti‐tumor effects in a mouse model of TNBC, with a tumor growth inhibition rate of 79.9%, and a pulmonary metastasis rate of 96.8%. Altogether, the combination strategy developed in this study can improve the efficacy of chemo/chemodynamic therapy in TNBC and represents an innovative application of EGCG.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Tea Biology and Resource Utilization of Ministry of Agriculture, Tea Research Institute, Chinese Academy of Agricultural Sciences, Hangzhou, 310008, P. R. China.
- School of Food and Biological Engineering, Shaanxi University of Science & Technology, Xi'an, 710021, P. R. China.
- Department of Orthopedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, P. R. China.
- MOE, Frontiers Science Center for Rare Isotopes, Lanzhou University, Lanzhou, 730000, P. R. China.
- Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, P. R. China.
ORCID-Profile: Mengxue Zhou
Förderung
- Central Public-interest Scientific Institution Basal Research Fund
- Chinese Academy of Agricultural Sciences
- Zhejiang Provincial Outstanding Youth Science Foundation
- Key Research and Development Program of Zhejiang Province
- National Natural Science Foundation of China
- Basic Public Welfare Research Program of Zhejiang Province
Zitieren
APA
Zhou, M., Zhou, C., Geng, H., Huang, Z., Lin, Z., Wang, Y., Zhu, Y., Shi, J., Tan, J., Guo, L., Zhao, Y., Zhang, Y., Peng, Q., Yu, H., Dai, W., Lv, H., & Lin, Z. (2025). EGCG‐enabled Deep Tumor Penetration of Phosphatase and Acidity Dual‐responsive Nanotherapeutics for Combinatory Therapy of Breast Cancer. Small. https://doi.org/10.1002/smll.202406245
Vancouver
Zhou M, Zhou C, Geng H, Huang Z, Lin Z, Wang Y, et al. EGCG‐enabled Deep Tumor Penetration of Phosphatase and Acidity Dual‐responsive Nanotherapeutics for Combinatory Therapy of Breast Cancer. Small. 2025. doi:10.1002/smll.202406245
BibTeX
@article{Zhou2025,
author = {Zhou, Mengxue and Zhou, Chuang and Geng, Huan and Huang, Zhiwei and Lin, Zhiyuan and Wang, Ying and Zhu, Yin and Shi, Jiang and Tan, Junfeng and Guo, Li and Zhao, Yanni and Zhang, Yue and Peng, Qunhua and Yu, Haijun and Dai, Weidong and Lv, Haipeng and Lin, Zhi},
title = {EGCG‐enabled Deep Tumor Penetration of Phosphatase and Acidity Dual‐responsive Nanotherapeutics for Combinatory Therapy of Breast Cancer},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202406245}
}
EUVIMED